Sunshine Biopharma feels it has a “solid position in the generic prescription drugs industry,” and is “closer to our objective of becoming a fully-integrated pharma company,” after completing its acquisition of fellow Canadian firm Nora Pharma.
Montreal-based Sunshine Biopharma has paid CAD30m ($21
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?